Invest now
Torrent Pharmaceuticals share price
Moderate risk
You have to be logged in to add this to Watchlist.- ₹4,755.15(-0.14%)October 5, 2026 15:30:05 PM IST
- NSE
- BSE
- Vol : 336.64 K (NSE + BSE)Last 20 day avg : 373.82 K
Torrent Pharmaceuticals is trading -0.14% lower at Rs 4,755.15 as compared to its last closing price. Torrent Pharmaceuticals has been trading in the price range of 4,793.55 & 4,708.85. Torrent Pharmaceuticals has given 23.83% in this year & -3.27% in the last 5 days. Torrent Pharmaceuticals has TTM P/E ratio 73.81 as compared to the sector P/E of 33.86.There are 29 analysts who have initiated coverage on Torrent Pharmaceuticals. There are 9 analysts who have given it a strong buy rating & 12 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.The company posted a net profit of 566.00 Crores in its last quarter.Listed peers of Torrent Pharmaceuticals include Sun Pharmaceutical Industries (-1.55%), Divi's Laboratories (-0.88%), Cipla (-0.95%).The Mutual Fund holding in Torrent Pharmaceuticals was at 8.27% in 20 Jul 2026. The MF holding has increased from the last quarter. The FII holding in Torrent Pharmaceuticals was at 17.97% in 20 Jul 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 06 Oct 2026, 03:21 AM IST
- BetaLow volatility0.66Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry1.79The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.80Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation3.77The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Torrent Pharmaceuticals News
Torrent Pharmaceuticals Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,782.00 | -1.55 | 4,27,551.42 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,212.85 | -0.88 | 2,44,572.22 | 73.32 | 11.48 | 0.41 | 0.03 |
| Cipla | 1,334.00 | -0.95 | 1,07,768.31 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,138.50 | -0.59 | 1,13,565.81 | 21.19 | 4.24 | 0.09 | 14.22 |
| Lupin | 2,010.00 | -0.94 | 91,910.44 | 19.12 | 4.98 | 0.74 | 9.53 |
Mutual Fund Ownership
View allTorrent Pharmaceuticals Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-30 | Quarterly Results |
| 2026-05-22 | Audited Results, Dividend & Fund Raising |
| 2026-02-13 | Quarterly Results & Interim Dividend |
| 2026-01-05 | Others |
| 2025-11-07 | Quarterly Results |
About the company Torrent Pharmaceuticals
- IndustryBiotechnology & Drugs
- ISININE685A01028
- BSE Code500420
- NSE CodeTORNTPHARM
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The Company focuses on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI), women healthcare (WHC), Vitamins Minerals & Nutrients (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynecology, oncology and anti-infective segments. Its brands include Ahaglow, Shelcal, Tedibar, and Unienzyme. Its tedibar brands include Tedibar bathing bar, Tedibar Atogla, Tedibar Spoo and Tedibar B4 Nappi. Its Shelcal includes Shelcal 500, Shelcal Pro Gummies, Kids Gummies, and Shelcal Total. The Company's manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim.
Torrent Pharmaceuticals Share Price FAQs
Torrent Pharmaceuticals is trading at 4755.15 as on Mon Oct 05 2026 10:00:05. This is -0.14% lower as compared to its previous closing price of 4761.95.
The market capitalization of Torrent Pharmaceuticals is 180864.15 Cr as on Mon Oct 05 2026 10:00:05.
The average broker rating on Torrent Pharmaceuticals is Buy. The breakup of analyst rating is given below -
- 9 analysts have given a strong buy rating
- 12 analysts have given a buy rating
- 6 analysts have given a hold rating
- 2 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Torrent Pharmaceuticals is 5249.95 whereas the 52 wk low is 3480.00
Torrent Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 73.81
- Sector P/E: 33.86
- Dividend Yield: 0.80%
- D/E ratio: -
Torrent Pharmaceuticals reported a net profit of 2163.37 Cr in 2026.
The Mutual Fund Shareholding was 8.27% at the end of 20 Jul 2026.
Quick Links
EQUITY QUICK LINKS
Torrent Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.